trans-Resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: Electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism

Journal of Neurochemistry

Volumn 75, Issue 1, 2000, Pages 141-150

  Karlsson, Jenny ^a   Emgård, Mia ^a   Brundin, Patrik ^a   Burkitt, Mark J ^b  

^a LUND UNIVERSITY   (Sweden)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Electron paramagnetic resonance spin trapping; Free radicals; Neuroprotection; Parkinson's disease; tert Butyl hydroperoxide; trans Resveratrol

Indexed keywords

RESVERATROL; SCAVENGER; TERT BUTYL HYDROPEROXIDE;

ANIMAL CELL; ARTICLE; CELL SUSPENSION; CHEMICAL REACTION; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; ELECTRON SPIN RESONANCE; EMBRYO; EMBRYO CELL; GRAPE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; WINE;

ANIMALS; ANTIOXIDANTS; COUMARINS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; FREE RADICAL SCAVENGERS; FREE RADICALS; HYDROXYL RADICAL; L-LACTATE DEHYDROGENASE; MESENCEPHALON; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS; STILBENES; TERT-BUTYLHYDROPEROXIDE;

ANIMALIA; VITACEAE; VITIS SP.;

EID: 0342656571     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750141.x     Document Type: Article

References (47)

1. Bavaresco L., Fregoni C., Cantu E., and Trevisan M. (1999) Stilbene compounds: from grapevine to wine. Drugs Exp. Clin. Res. 25, 57-63.
2. Beal M. F. (1996) Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6, 661-666.
3. Belguendouz L., Fremont L., and Linard A. (1997) Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53, 1347-1355.
4. Brundin P., Karlsson J., Emgård M., Kaminski Schierle G. S., Hansson O., Petersén Å., and Castilho R. F. (2000a) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. (in press).
5. Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P., Gustavii B., Björklund A., Brooks D. J., Marsden C. D., Oertel W. H., Quinn N. P., Rehncrona S., and Lindvall O. (2000b) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (in press).
6. Buettner G. R. (1987) Spin trapping: ESR parameters of spin adducts. Free Radic. Biol. Med. 3, 259-303.
7. Burkitt M. J. and Gilbert B. C. (1990) Model studies of the iron-catalysed Haber-Weiss cycle and the ascorbate-driven Fenton reaction. Free Radic. Res. Commun. 10, 265-280.
8. 2 mixtures: effects of metal ion chelation and the search for high-valent metal-oxygen intermediates. Arch. Biochem. Biophys. 323, 63-70.
9. Carbó N., Costelli P., Baccino F. M., López-Soriano F. J., and Argilés J. M. (1999) Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 254, 739-743.
10. Celotti E., Ferrarini R., Zironi R., and Conte L. S. (1996) Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J. Chromatogr. A 730, 47-52.
11. Chanvitayapongs S., Draczynska-Lusiak B., and Sun A. Y. (1997) Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 8, 1499-1502.
12. Davies M. J. (1989) Detection of peroxyl and alkoxyl radicals produced by reaction of hydroperoxides with rat liver microsomal fractions. Biochem. J. 257, 603-606.
13. Davies M. J., Gilbert B. C., Stell J. K., and Whitwood A. C. (1992) Nucleophilic substitution reactions of spin adducts. Implications for the correct identification of reaction intermediates by ESR/spin trapping. J. Chem. Soc. Perkin Trans. 2, 333-335.
14. Dikalov S. I. and Mason R. P. (1999) Reassignment of organic peroxyl radical adducts. Free Radic. Biol. Med. 27, 864-872.
15. Duling D. (1994) Simulation of multiple isotropic spin-trap EPR spectra. J. Magn. Res. B 104, 105-110.
16. ElAttar T. M. and Virji A. S. (1999) Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anti-cancer Drugs 10, 187-193.
17. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
18. Finkelstein E., Rosen G. M., and Rauckman E. J. (1980) Spin trapping. Kinetics of the reaction of superoxide and hydroxyl radicals with nitrones. J. Am. Chem. Soc. 102, 4994-4999.
19. Frodl E. M., Nakao N., and Brundin P. (1994) Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. Neuroreport 5, 2393-2396.
20. Gehm B. D., McAndrews J. M., Chien P.-Y., and Jameson J. L. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94, 14138-14143.
21. Grasbon-Frodl E. M., Andersson A., and Brundin P. (1996) Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67, 1653-1660.
22. Hsieh T. C. and Wu J. M. (1999) Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 249, 109-115.
23. Huang C., Ma W. Y., Goranson A., and Dong Z. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20, 237-242.
24. Jang D. S., Kang B. S., Ryu S. Y., Chang I. M., Min K. R., and Kim Y. (1999) Inhibitory effects of resveratrol analogs on unopsonized zymogen-induced oxygen radical production. Biochem. Pharmacol. 57, 705-712.
25. Jang M., Cai L., Udeani G. O., Slowing K. V., Thomas C. F., Beecher C. W. W., Fong H. H. S., Farnsworth N. R., Kinghorn A. D., Mehta R. G., Moon R. C., and Pezzuto J. M. (1997) Cancer chemopreventative activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
26. Kaminski Schierle G. S., Hansson O., and Brundin P. (1999) Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience 94, 17-20.
27. Karlsson J., Love R. M., Clarke D. J., and Brundin P. (1999) Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones. Brain Res. 821, 546-550.
28. Kennedy C. H., Church D. F., Winston G. W., and Pryor W. A. (1992) tert-Butyl hydroperoxide-induced radical production in rat liver mitochondria. Free Radic. Biol. Med. 12, 381-387.
29. Kopp P. (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the "French paradox"? Eur. J. Endocrinol. 138, 619-620.
30. Lindvall O. (1999) Cerebral implantation in movement disorders: state of the art. Mor. Disord. 14, 201-205.
31. MacCarrone M., Lorenzon T., Guerrieri P., and Agro A. F. (1999) Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265, 27-34.
32. Makino K., Hagiwara T., Hagi A., Nishi M., and Murakami A. (1990) Cautionary note for DMPO spin trapping in the presence of iron. Biochem. Biophys. Res. Commun. 172, 1073-1080.
33. Masaki N., Kyle M. E., and Farber J. L. (1989) tert-Butyl hydroperoxide kills cultured hepatocytes by peroxidizing membrane lipids. Arch. Biochem. Biophys. 269, 390-399.
34. Mason R. P., Hanna P. M., Burkiti M. J., and Kadiiska M. B. (1994) Detection of oxygen-derived radicals in biological systems using electron spin resonance. Environ. Health Perspect. 102 (Suppl. 10), 33-36.
35. Miloso M., Bertelli A. A., Nicolini G., and Tredici G. (1999) Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 264, 141-144.
36. Nakao N., Frodl E. M., Duan W.-M., Widner H., and Brundin P. (1994) Lazaroids improve the survival of grafted embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 91, 12408-12412.
37. Nakao N., Frodl E. M., Widner H., Carlson E., Eggerding F. A., Epstein C. J., and Brundin P. (1995) Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1, 226-231.
38. O'Donnell V. and Burkitt M. J. (1994) Mitochondrial metabolism of a hydroperoxide to free radicals in human endothelial cells: an electron spin resonance spin-trapping investigation. Biochem. J. 304, 707-713.
39. Olanow C. W. (1993) A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444.
40. Othberg A., Keep M., Brundin P., and Lindvall O. (1997) Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro. Exp. Neurol. 147, 498-502.
41. Pace-Asciak C. R., Hahn S., Diamandis E. P., Soleas G., and Goldberg D. M. (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta 235, 207-219.
42. Schwekendiek A., Pfeffer G., and Kindl H. (1992) Pine stilbene synthase cDNA, a tool for probing environmental stress. FEBS Lett. 301, 41-44.
43. Soleas G. J., Diamandis E. P., and Goldberg D. M. (1997) Resveratrol: a molecule whose time has come? and gone? Clin. Biochem. 30, 91-113.
44. Stewart J. R., Ward N. E., Ionnides C. G., and O'Brian C. A. (1999) Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry 38, 13244-13251.
45. Taniguchi H. and Madden K. P. (1999) An in situ radiolysis time-resolved ESR study of the kinetics of spin trapping by 5,5-dimethyl-1-pyrroline-N-oxide. J. Am. Chem. Soc. 121, 11875-11879.
46. Timmins G. S. and Davies M. J. (1993) Free radical formation in isolated murine keratinocytes treated with organic peroxides and its modulation by antioxidants. Carcinogenesis 14, 1615-1620.
47. Tsai S. H., Lin-Shiau S. Y., and Lin J. K. (1999) Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126, 673-680.